Kestra Advisory Services’s Teva Pharmaceuticals TEVA Stock Holding History

Kestra Advisory Services’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.56M	Sell	46,085 -1,303	-3%	-$43.4K	0.01%	1507
2026 Q1	$1.43M	Buy	47,388 +1,031	+2%	+$33.2K	0.01%	1501
2025 Q4	$1.45M	Buy	46,357 +4,482	+11%	+$110K	0.01%	1413
2025 Q3	$846K	Sell	41,875 -1,173	-3%	-$20.6K	﹤0.01%	1697
2025 Q2	$721K	Buy	43,048 +4,570	+12%	+$73.7K	﹤0.01%	1705
2025 Q1	$591K	Sell	38,478 -5,994	-13%	-$107K	﹤0.01%	1705
2024 Q4	$980K	Buy	44,472 +6,482	+17%	+$118K	0.01%	1432
2024 Q3	$685K	Sell	37,990 -5,994	-14%	-$105K	﹤0.01%	1559
2024 Q2	$638K	Buy	43,984 +4,363	+11%	+$67.2K	﹤0.01%	1618
2024 Q1	$559K	Buy	+39,621	New	+$499K	﹤0.01%	1598
2023 Q2	–	Sell	-10,251	Closed	-$90.7K	–	2185
2023 Q1	$90.7K	Sell	10,251 -10,115	-50%	-$100K	﹤0.01%	1963
2022 Q4	$186K	Buy	20,366 +5,380	+36%	+$46.9K	﹤0.01%	2043
2022 Q3	$121K	Sell	14,986 -24,855	-62%	-$220K	﹤0.01%	1959
2022 Q2	$300K	Buy	39,841 +29,510	+286%	+$257K	﹤0.01%	1625
2022 Q1	$97K	Sell	10,331 -2,568	-20%	-$21.4K	﹤0.01%	1934
2021 Q4	$103K	Buy	12,899 +793	+7%	+$7.16K	﹤0.01%	1936
2021 Q3	$118K	Buy	12,106 +1,507	+14%	+$14.1K	﹤0.01%	2043
2021 Q2	$105K	Sell	10,599 -7,238	-41%	-$76.6K	﹤0.01%	1950
2021 Q1	$206K	Sell	17,837 -35,974	-67%	-$413K	﹤0.01%	1717
2020 Q4	$517K	Buy	53,811 +17,601	+49%	+$169K	0.01%	1189
2020 Q3	$327K	Buy	+36,210	New	+$383K	0.01%	1067

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Kestra Advisory Services's TEVA Position: Q2 2026 in Review

Kestra Advisory Services reduced its Teva Pharmaceuticals (TEVA) stake by 2.7% in Q2 2026, selling an estimated $43.4K and leaving 46,085 shares worth $1.56M. The position accounts for 0.01% of the portfolio, ranked #1507.

Kestra Advisory Services first reported a position in TEVA in Q3 2020 and has held it in 21 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Kestra Advisory Services held 46,085 shares of Teva Pharmaceuticals worth $1.56M as of Q2 2026.
Kestra Advisory Services sold 1,303 Teva Pharmaceuticals shares in Q2 2026, an estimated $43.4K.
Teva Pharmaceuticals made up 0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #1507 holding.
Kestra Advisory Services first reported a position in Teva Pharmaceuticals in Q3 2020 and has held it in 21 quarters since.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.